Failure of fixed dose intravenous heparin to suppress increases in thrombin activity after coronary thrombolysis with streptokinase
- 15 November 1994
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 24 (6), 1445-1452
- https://doi.org/10.1016/0735-1097(94)90138-4
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- Importance of factor Xa in determining the procoagulant activity of whole-blood clots.Journal of Clinical Investigation, 1993
- Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.Journal of Clinical Investigation, 1990
- In-hospital mortality and clinical course of 20 891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparinThe Lancet, 1990
- Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury.Journal of Clinical Investigation, 1989
- Paradoxic elevation of fibrinopeptide A after streptokinase: Evidence for continued thrombosis despite intense fibrinolysisJournal of the American College of Cardiology, 1987
- High-dose, brief-duration intravenous infusion of streptokinase in acute myocardial infarction: Description of effects in the circulationThe American Journal of Cardiology, 1986
- Importance of continued activation of thrombin reflected by fibrinopeptide A to the efficacy of thrombolysisJournal of the American College of Cardiology, 1986
- Fibrinopeptide A: a marker of acute coronary thrombosis.Circulation, 1985
- Effect of heparin on plasma fibrinopeptide A in patients with acute myocardial infarction.Circulation, 1984